ArticleClinical cancer research : an official journal of the American Association for Cancer Research2025

Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade.

Samuel Rosner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.